Methotrexate in Rheumatoid Arthritis
- 28 March 1985
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 312 (13) , 853-854
- https://doi.org/10.1056/nejm198503283121310
Abstract
Many drugs currently used in the treatment of rheumatoid arthritis were originally suggested around 1950. The first clinical studies of antimalarial agents, alkylating agents, sulfasalazine, analogues of folic acid, and corticosteroids were performed during that period. The dramatic effects produced by corticosteroids tended to eclipse consideration of alternative forms of drug therapy for nearly a decade. With the recognition that corticosteroids have substantial toxicity and do not alter fundamental disease processes, attention has slowly turned to a reexamination of the other drugs.The folic acid antagonist methotrexate is the latest drug to undergo this careful scrutiny. An early study of . . .Keywords
This publication has 8 references indexed in Scilit:
- Efficacy of Low-Dose Methotrexate in Rheumatoid ArthritisNew England Journal of Medicine, 1985
- Constitutive Fragile Sites and CancerScience, 1984
- Rheumatoid Arthritis: Evolving Concepts of Pathogenesis and TreatmentAnnals of Internal Medicine, 1984
- Symposium: Surgery of the upper extremity in rheumatoid arthritisArthritis & Rheumatism, 1984
- Methotrexate guidelines—revisedJournal of the American Academy of Dermatology, 1982
- Is methotrexate therapy for psoriasis carcinogenic? A modified retrospective-prospective analysisPublished by American Medical Association (AMA) ,1975
- Methotrexate Therapy in Psoriatic ArthritisPublished by American Medical Association (AMA) ,1964
- THERAPEUTIC SUPPRESSION OF TISSUE REACTIVITYThe Lancet Healthy Longevity, 1951